Literature DB >> 24717910

Revised surveillance case definition for HIV infection--United States, 2014.

.   

Abstract

Following extensive consultation and peer review, CDC and the Council of State and Territorial Epidemiologists have revised and combined the surveillance case definitions for human immunodeficiency virus (HIV) infection into a single case definition for persons of all ages (i.e., adults and adolescents aged ≥13 years and children aged <13 years). The revisions were made to address multiple issues, the most important of which was the need to adapt to recent changes in diagnostic criteria. Laboratory criteria for defining a confirmed case now accommodate new multitest algorithms, including criteria for differentiating between HIV-1 and HIV-2 infection and for recognizing early HIV infection. A confirmed case can be classified in one of five HIV infection stages (0, 1, 2, 3, or unknown); early infection, recognized by a negative HIV test within 6 months of HIV diagnosis, is classified as stage 0, and acquired immunodeficiency syndrome (AIDS) is classified as stage 3. Criteria for stage 3 have been simplified by eliminating the need to differentiate between definitive and presumptive diagnoses of opportunistic illnesses. Clinical (nonlaboratory) criteria for defining a case for surveillance purposes have been made more practical by eliminating the requirement for information about laboratory tests. The surveillance case definition is intended primarily for monitoring the HIV infection burden and planning for prevention and care on a population level, not as a basis for clinical decisions for individual patients. CDC and the Council of State and Territorial Epidemiologists recommend that all states and territories conduct case surveillance of HIV infection using this revised surveillance case definition.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24717910

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN: 1057-5987


  83 in total

1.  Disparities and Delay in the Use of Guideline-Based Antiretroviral Therapy for Treatment of Pregnant Women with HIV in the Southeast United States.

Authors:  Ellery R Cohn; Jeffrey E Korte; Gweneth B Lazenby
Journal:  AIDS Patient Care STDS       Date:  2019-08-16       Impact factor: 5.078

2.  Trends and Racial Disparities of Late-Stage HIV Diagnosis: Hawaii, 2010-2016.

Authors:  Fenfang Li; Brandi K Juan; Michelle Wozniak; Stuart K Watson; Alan R Katz; Peter M Whiticar; Timothy McCormick; Yuanshan Sandy Qiu; Glenn M Wasserman
Journal:  Am J Public Health       Date:  2018-11       Impact factor: 9.308

3.  The effect of stage of HIV disease as determined by CD4 count on clinical outcomes of surgical sepsis in South Africa.

Authors:  S Green; V Y Kong; G L Laing; J L Bruce; J Odendaal; B Sartorius; D L Clarke
Journal:  Ann R Coll Surg Engl       Date:  2017-07       Impact factor: 1.891

4.  Risk of congenital cytomegalovirus infection among HIV-exposed uninfected infants is not decreased by maternal nelfinavir use during pregnancy.

Authors:  Soren Gantt; Erin Leister; Denise L Jacobsen; Isabelle Boucoiran; Meei-Li Huang; Keith R Jerome; Gonzague Jourdain; Nicole Ngo-Giang-Huong; Sandra Burchett; Lisa Frenkel
Journal:  J Med Virol       Date:  2015-11-18       Impact factor: 2.327

5.  The association between oral disease and type of antiretroviral therapy among perinatally HIV-infected youth.

Authors:  Caroline H Shiboski; Tzy-Jyun Yao; Jonathan S Russell; Mark I Ryder; Russell B Van Dyke; George R Seage; Anna-Barbara Moscicki
Journal:  AIDS       Date:  2018-11-13       Impact factor: 4.177

6.  Low Prevalence of Hepatitis B Vaccination Among Patients Receiving Medical Care for HIV Infection in the United States, 2009 to 2012.

Authors:  John Weiser; Alejandro Perez; Heather Bradley; Hope King; R Luke Shouse
Journal:  Ann Intern Med       Date:  2017-12-26       Impact factor: 25.391

Review 7.  Cancer in adolescents and young adults living with HIV.

Authors:  Julia Bohlius; Caroline Foster; Gita Naidu; Mazvita Sengayi; Anna Turkova
Journal:  Curr Opin HIV AIDS       Date:  2018-05       Impact factor: 4.283

8.  HIV Outbreak Control With Effective Access to Care and Harm Reduction in North Carolina, 2017-2018.

Authors:  Erika Samoff; Victoria Mobley; Michelle Hudgins; Anna Barry Cope; Nicole Dzialowy Adams; Christina R Caputo; Ann M Dennis; Rachael M Billock; Christy A Crowley; Jacquelyn M Clymore; Evelyn Foust
Journal:  Am J Public Health       Date:  2020-01-16       Impact factor: 9.308

9.  Using a Multitest Algorithm to Improve the Positive Predictive Value of Rapid HIV Testing and Linkage to HIV Care in Nonclinical HIV Test Sites.

Authors:  Kevin P Delaney; Jacqueline Rurangirwa; Shelley Facente; Teri Dowling; Mike Janson; Thomas Knoble; Annie Vu; Yunyin W Hu; Peter R Kerndt; Jan King; Susan Scheer
Journal:  J Acquir Immune Defic Syndr       Date:  2016-01-01       Impact factor: 3.731

10.  Lymphopenia and its association with survival in patients with locally advanced cervical cancer.

Authors:  Emily S Wu; Titilope Oduyebo; Lauren P Cobb; Diana Cholakian; Xiangrong Kong; Amanda N Fader; Kimberly L Levinson; Edward J Tanner; Rebecca L Stone; Anna Piotrowski; Stuart Grossman; Kara Long Roche
Journal:  Gynecol Oncol       Date:  2015-11-11       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.